Levofloxacin en es it fr

Categoria

Levofloxacin Marchi, Levofloxacin Analoghi

Levofloxacin Marchi miscela

  • No information avaliable
  • Levofloxacin Formula chimica

    C36H42F2N6O9

    Levofloxacin RX link

    http://www.rxlist.com/cgi/generic2/quixin.htm

    Levofloxacin FDA foglio

    Levofloxacin FDA

    Levofloxacin DMS (foglio di materiale di sicurezza)

    Levofloxacin Sintesi di riferimento

    Mitscher, Lester A. et al,. J.Med.Chem;. 30, 12, 2283-2286 (1987)

    Levofloxacin Peso molecolare

    740.751 g/mol

    Levofloxacin Temperatura di fusione

    No information avaliable

    Levofloxacin H2O Solubilita

    Insolubile

    Levofloxacin Stato

    Solid

    Levofloxacin LogP

    1.268

    Levofloxacin Forme di dosaggio

    Compressa, liquidi; Soluzione

    Levofloxacin Indicazione

    Per il trattamento della congiuntivite batterica causata da ceppi sensibili dei seguenti organismi: specie Corynebacterium, Staphylococus aureus, Staphylococcus epidermidis, Streptococcus pneumoniae, , Streptococcus (Gruppi C / F / G), gli streptococchi del gruppo viridans, Acinetobacter lwoffii, Haemophilus influenzae, Serratia marcescens.

    Levofloxacin Farmacologia

    Levofloxacina, un fluorochinolone antinfettivo, è otticamente attivo L-isomero di ofloxacina. Levofloxacina è usato per trattare la congiuntivite batterica, sinusite, bronchite cronica, polmonite acquisita in comunità e polmonite causata da ceppi resistenti alla penicillina di Streptococcus pneumoniae, infezioni della struttura della pelle e della pelle, infezioni complicate delle vie urinarie e pielonefrite acuta.

    Levofloxacin Assorbimento

    L'assorbimento di ofloxacina dopo dosi singole o multiple da 200 a 400 mg è prevedibile, e la quantità di farmaco assorbita aumenta proporzionalmente con la dose.

    Levofloxacin Tossicita

    Gli effetti collaterali includono disorientamento, vertigini, sonnolenza, vampate di calore e di freddo, nausea, impastando di parola, gonfiore e intorpidimento del viso

    Levofloxacin Informazioni paziente

    PATIENT INFORMATION

    While taking ofloxacin patient should be advised to:

    to drink fluids liberally;

    that mineral supplements, vitamins with iron or minerals, calcium- , aluminum-, or magnesium-based antacids, sucralfate or Videx, (Didanosine), chewable/buffered tablets or the pediatric powder for oral solution should not be taken within the two-hour period before or within the two-hour period after taking ofloxacin;

    that ofloxacin can be taken without regard to meals;

    that ofloxacin may cause neurologic adverse effects (e. g. , dizziness, lightheadedness) and that patients should know how they react to ofloxacin before they operate an automobile or machinery or engage in activities requiring mental alertness and coordination;

    to discontinue treatment and inform their physician if they experience pain, inflammation, or rupture of a tendon, and to rest and refrain from exercise until the diagnosis of tendinitis or tendon rupture has been confidently excluded;

    that ofloxacin may be associated with hypersensitivity reactions, even following the first dose, to discontinue the drug at the first sign of a skin rash, hives or other skin reactions, a rapid heartbeat, difficulty in swallowing or breathing, any swelling suggesting angioedema (e. g. , swelling of the lips, tongue, face; tightness of the throat, hoarseness), or any other symptom of an allergic reaction

    to avoid excessive sunlight or artificial ultraviolet light while receiving ofloxacin and to discontinue therapy if phototoxicity (e. g. , skin eruption) occurs;

    that if they are diabetic and are being treated with insulin or an oral hypoglycemic drug, to discontinue ofloxacin immediately if a hypoglycemic reaction occurs and consult a physician;

    that convulsions have been reported in patients taking quinolones, including ofloxacin, and to notify their physician before taking this drug if there is a history of this condition.

    Levofloxacin Atto interessato organismi

    Batteri enterici e altri eubatteri